🇺🇸 FDA
Patent

US 10463685

Telomerase mediated telomere altering compounds

granted A61KA61K31/7076A61K31/7088

Quick answer

US patent 10463685 (Telomerase mediated telomere altering compounds) held by The Board of Regents of the University of Texas System expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/7076, A61K31/7088, A61K45/06, A61P